Document Detail

Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure.
MedLine Citation:
PMID:  8834084     Owner:  NLM     Status:  MEDLINE    
The CLIA '88 regulations require the laboratory to review at least 10% of the gynecologic cases interpreted as negative that are examined by each cytotechnologist. The review must include negative cases selected at random and from patients identified as a high risk group. To evaluate the validity of this regulation, we reviewed the results of the 10% rescreen over a 24-mo period. The rescreening by pathologists detected epithelial abnormalities in 4/2,124 negative cases (0.18%). Subsequently, biopsy-proven squamous intraepithelial lesions were found in all four cases. Three different cytotechnologists were responsible for the four false-negative interpretations. Our results show that 10% rescreen of negative smears may detect a few false-negative cases. However, it is a time-consuming and inefficient mean to evaluate the performance of cytotechnologists. Quality control in gynecologic cytopathology is essential, but it is equally important that laboratories concentrate their resources and energy on methods proven to be effective.
S O Tabbara; M K Sidawy
Related Documents :
12945064 - Dimensional versus categorical classification of prototypic and nonprototypic cases of ...
16519814 - Evaluation of quadas, a tool for the quality assessment of diagnostic accuracy studies.
21851224 - Beyond diagnosis- and therapy-centred therapy: the case for incorporating contextual fa...
20349154 - Narrative review: should teaching of the respiratory physical examination be restricted...
17988384 - Pleural myxoid liposarcoma: features of 2 cases and associated literature review.
15317034 - Clinical review procedures for the antiretroviral pregnancy registry.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Diagnostic cytopathology     Volume:  14     ISSN:  8755-1039     ISO Abbreviation:  Diagn. Cytopathol.     Publication Date:  1996 Feb 
Date Detail:
Created Date:  1996-12-10     Completed Date:  1996-12-10     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  8506895     Medline TA:  Diagn Cytopathol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  84-6     Citation Subset:  IM    
Department of Pathology, George Washington University Medical Center, Washington, D.C. 20037, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cervical Intraepithelial Neoplasia / diagnosis*,  pathology*
False Negative Reactions
Mass Screening / standards*
Quality Assurance, Health Care*
Sensitivity and Specificity
Uterine Cervical Neoplasms / diagnosis*,  pathology*
Vaginal Smears* / standards
Comment In:
Diagn Cytopathol. 1997 Feb;16(2):191-2   [PMID:  9067119 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mimics of pilomatrixomas in fine-needle aspirates.
Next Document:  Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central...